Pharmacotherapeutic Blood Pressure Management in a Chronic Kidney Disease Patient
Francine Salinitri, PharmD, Helen Berlie, PharmD, Neha Desai, PharmD 
 
 
Learning Objectives - At the completion of this program, the learner will be able to:
Objective 1: Discuss the mechanisms of action for selected antihypertensive drugs (angiotensin converting enzyme inhibitors [ACEIs], angiotensin receptor blockers [ARBs], ß-blockers [BBs], calcium channel blockers [CCBs] and diuretics) used in the treatment of ch
Objective 2: Describe the modifications needed for dosing the CKD patient with ACEI, ARB, BB, CCB, and diuretics based on creatinine clearance.
Objective 3: Understand the place in therapy for these antihypertensive agents in the multidrug treatment of patients with hypertension and CKD.
 
CE ID: ACC2031 Contact Hours: 1.0
CERP Cat: A Synergy Cat: A
Form Expires: 6/1/2011
 
Program Title and Description
Pharmacotherapeutic Blood Pressure Management in a Chronic Kidney Disease Patient
Publication/Sponsor Information
All rights reserved. No part of this book may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in critical articles or reviews. Permission to photocopy articles: This publication is protected by copyright. Permission to photocopy must be secured in writing from: Permissions Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106-3621; fax: 215-521-8466 or Copyright Clearance Center CCC, 222 Rosewood Dr., Danvers, MA 01923; phone: 978-750-8400; fax: 978-750-4470; www.copyright.com.
 
 
Click on the title below to view
Pharmacotherapeutic Blood Pressure Management in a Chronic Kidney Disease Patient
In order to read some of the CE content you will need to download the following FREE reader:
 
 
Take Test Return